Congestive heart failure最新文献

{"title":"Advancing the Advances in Heart Failure: Updates on Newer Therapies","authors":"M. Silver","doi":"10.1111/J.1527-5299.2005.04779.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2005.04779.X","url":null,"abstract":"Marc A. Silver, MD, Co-Editor in Chief From the Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL Address for correspondence: Marc A. Silver, MD, Chairman and Clinical Professor, Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, 4440 West 95th Street, Suite 319 South, Oak Lawn, IL 60453-2600 E-mail: marc.silver@advocatehealth.com In January 2005, we issued a call for papers to focus on updates on some of the new and emerging therapies for patients with heart failure. We specifically asked potential authors to focus on biventricular resynchronization and left ventricular assist devices. This focus was prudent, because although clinical trial publications and early adoption of these strategies were of recent vintage, we felt that these were two key therapeutic areas where the field was evolving on a daily basis. Furthermore, as a heart failure community, we must test our tools every day. There is no room here for a strategy or therapy that does not provide continued significant improvement in heart failure outcomes for patients. So the call went out and authors responded. Included in this issue are four of these papers. One deals with updates on selecting responders to resynchronization therapy—a hot topic indeed. Two others deal with advances in patient selection and care for potential left ventricular assist device recipients and potential new complications to be aware of. We are also pleased to have the excellent paper by Faris and colleagues representing an important FDA perspective on both resynchronization and left ventricular assist devices. And as these papers are published, it is my hope that they soon become obsolete. We should push ourselves to test the methods and resources we use for heart failure patients every day. We should continue to speak among ourselves and to others about these advances. In that context, Congestive Heart Failure will continue to publish periodic focus issues like this. In an electronic age, we should be able to spread best practices liberally to those who provide the care; it is our pledge to be part of that dissemination of current knowledge.","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"18 1","pages":"176-176"},"PeriodicalIF":0.0,"publicationDate":"2005-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88733841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. Short-Term Risk of Death After Treatment With Nesiritide for Decompensated Heart Failure","authors":"I. S. Virk, John Ip","doi":"10.1111/j.1527-5299.2005.04176.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2005.04176.x","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"236 1","pages":"216-218"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82441990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insulin Ameliorates Exercise Ventilatory Efficiency and Oxygen Uptake in Patients With Heart Failure-Type 2 Diabetes Comorbidity","authors":"M. Kamboj, S. Kantipudi, Atul Khasais, R. Thakur","doi":"10.1111/J.1527-5299.2003.02318.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02318.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"1 1","pages":"347-348"},"PeriodicalIF":0.0,"publicationDate":"2003-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79847321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.","authors":"W. Abraham, B. Massie, M. Lukas, S. Lottes, J. Nelson, M. Fowler, B. Greenberg, E. Gilbert, J. Franciosa","doi":"10.1016/S0735-1097(04)91775-5","DOIUrl":"https://doi.org/10.1016/S0735-1097(04)91775-5","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"14 1","pages":"16-21"},"PeriodicalIF":0.0,"publicationDate":"2003-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77995045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Orlistat in obese patients with heart failure: a pilot study.","authors":"L. Beck-da-Silva, L. Higginson, M. Fraser, K. Williams, H. Haddad","doi":"10.1016/S1071-9164(03)00167-2","DOIUrl":"https://doi.org/10.1016/S1071-9164(03)00167-2","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"10 13 1","pages":"118-23"},"PeriodicalIF":0.0,"publicationDate":"2003-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87234882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Consultation Between Generalists and Cardiologists With Quality and Outcomes of Heart Failure Care","authors":"D. Tepper","doi":"10.1111/j.1527-5299.2003.02312.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2003.02312.x","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"22 1","pages":"230-231"},"PeriodicalIF":0.0,"publicationDate":"2003-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86457268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CME in CHF","authors":"M. Silver","doi":"10.1111/J.1527-5299.2003.02572.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02572.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"3 1","pages":"125-125"},"PeriodicalIF":0.0,"publicationDate":"2003-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80765148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Randomized Comparison of Enoxaparin With Unfractionated Heparin for the Prevention of Venous Thromboembolism in Medical Patients With Heart Failure or Severe Respiratory Disease","authors":"D. Tepper","doi":"10.1111/J.1527-5299.2003.02309.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02309.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"1 1","pages":"179-180"},"PeriodicalIF":0.0,"publicationDate":"2003-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86514561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Outcomes in Patients on Beta‐Blocker Therapy Admitted With Worsening Chronic Heart Failure","authors":"D. Tepper","doi":"10.1111/J.1527-5299.2003.01904.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.01904.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"520 1","pages":"106-107"},"PeriodicalIF":0.0,"publicationDate":"2003-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80116848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obstructive Sleep Apnea","authors":"D. Tepper","doi":"10.1111/j.1527-5299.2002.01530.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2002.01530.x","url":null,"abstract":"Obstructive sleep apnea syndrome (OSA) is a highly prevalent disorder affecting approximately 4 to 10% of adults that has been implicated in a large spectrum of end-organ morbidities. OSA is characterized by repetitive obstructions of the upper airway during sleep that result in intermittent hypoxia (IH), increased inspiratory efforts, and ultimately sleep fragmentation (SF). A large body of research has extensively examined some of the mechanisms underlying the cardiovascular, cognitive, and metabolic co-morbidities associated with OSA in both patient cohorts and murine models. In this setting, activation and propagation of inflammatory and oxidative stress pathways have emerged as leading mechanistic processes.","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"33 1","pages":"284-284"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75497902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}